In our 2021 experiment, AST reduced OS and showed a modest decrease in the rate of apoptosis in the GCs of a PCOS mouse model, and activated the PI3K/AKT pathway [70]. This evidence concerns the gene AKT1 and polycystic ovary syndrome.